Evidence map›Paper›PMID 20514556›Full record

ReviewCurrent hypertension reports2010

Vascular effects of antihypertensive drug therapy.

Asia Rehman, Ernesto L Schiffrin

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current hypertension reports, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Dronedarone induces regression of coronary artery remodeling related to better global antioxidant status.Hypertension research : official journal of the Japanese Society of Hypertension · 2019
    Article
  3. Vascular Aging and Disease of the Small Vessels.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2019
    Review
  4. Article
  5. Article
  6. Early regression of coronary artery remodeling with esmolol and DDAH/ADMA pathway in hypertensive rats.Hypertension research : official journal of the Japanese Society of Hypertension · 2016
    Article
  7. TLR4 as a possible key regulator of pathological vascular remodeling by Ang II receptor activation.Hypertension research : official journal of the Japanese Society of Hypertension · 2015
    Article
  8. Interactions between macro- and micro-circulation: are they relevant?High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2015
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Appropriateness of cardiovascular care in elderly adult cancer survivors.Medical oncology (Northwood, London, England) · 2013
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Asia RehmanLady Davis Institute, Sir Mortimer B. Davis-Jewish General Hospital, 3755 Côte-Ste-Catherine Road, Montreal, Quebec, Canada.
Ernesto L Schiffrin
Jewish General Hospital · CA

Funding

Canadian Institutes of Health Research 37137Canadian Institutes of Health Research 82790
6 · The paper itself

Abstract

Hypertension is associated with structural and functional alterations in the vasculature that lead to hemodynamic disturbances and target organ damage. The benefit of reducing blood pressure on risk reduction is well established. Antihypertensive drugs partially correct hypertensive vascular changes by a number of mechanisms, but their influence may vary in different vascular beds. Recently, combinations of drugs with complementary or synergistic effects have shown favorable effects on the vasculature; these combinations may contribute to risk reduction and improve outcomes in the future. Clinical trial evidence has shown an improvement in morbidity and mortality indicators that could be related to vascular effects of antihypertensive drugs, but this effect needs to be proven in future long-term prospective studies involving simultaneous evaluation of small-artery and large-artery properties.

Indexed as

Antihypertensive AgentsArteriesBlood PressureCardiovascular DiseasesCardiovascular SystemEndothelium, VascularHumansHypertensionRisk FactorsVentricular RemodelingAntihypertensive Agents

Identifiers

PMID20514556
OpenAlexW2021521258

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.